Organization Overview
Historical Acquisition Tree
Alternative names
Key: Sarepta Therapeutics (1) Acquired (39)
adalimumab (humira) (15 trials)
azacitidine (vidaza) (1 trial)
betahistine mesilate (1 trial)
carbamazepine (tegretol) (3 trials)
dalteparin (fragmin) (5 trials)
decitabine (dacogen) (32 trials)
denileukin diftitox (ontak) (14 trials)
eribulin (halaven) (72 trials)
fospropofol (lusedra) (19 trials)
golodirsen (Vyondys 53) (5 trials)
lemborexant (Dayvigo) (27 trials)
lenvatinib (lenvima) (100 trials)
lidocaine (xylocaine) (1 trial)
Key: Sarepta Therapeutics (3) Acquired (60)
adefovir dipivoxil (hepsera) (1 trial)
bexarotene (targretin) (3 trials)
cabozantinib (cometriq) (1 trial)
capecitabine (xeloda) (7 trials)
carboplatin (paraplatin) (14 trials)
cisplatin (platinol) (8 trials)
cytarabine (cytosar-u) (4 trials)
dacarbazine (dtic-dome) (2 trials)
diclofenac (voltaren) (2 trials)
eltrombopag (promacta) (1 trial)
eritoran tetrasodium (3 trials)
esomeprazole (nexium) (4 trials)
eszopiclone (lunesta) (5 trials)
eteplirsen (Exondys 51) (10 trials)
everolimus (zortress) (7 trials)
lamotrigine (lamictal) (1 trial)
levoleucovorin (fusilev) (1 trial)
oxaliplatin (eloxatin) (5 trials)
pembrolizumab (keytruda) (32 trials)
pemetrexed (alimta) (7 trials)
pertuzumab (perjeta) (2 trials)
Key: Sarepta Therapeutics (6) Acquired (66)
4-peptide melanoma vaccine (1 trial)
benznidazole (Rochagan) (1 trial)
bevacizumab (avastin) (6 trials)
calcipotriene (dovonex) (1 trial)
cetuximab (erbitux) (3 trials)
clofarabine (clolar) (1 trial)
colfosceril palmitate (1 trial)
epirubicin (ellence) (1 trial)
etoposide (vepesid) (3 trials)
filgrastim (neupogen) (1 trial)
fulvestrant (faslodex) (2 trials)
hyaluronidase (human recombinant) (hylenex) (1 trial)
idarubicin (idamycin) (1 trial)
interferon alpha-2b (Intron-A) (3 trials)
irinotecan (Camptosar) (6 trials)
ixabepilone (ixempra) (1 trial)
mitoxantrone (novantrone) (1 trial)
ondansetron (zofran) (2 trials)
prednisone (meticorten) (2 trials)
progesterone (progestasert) (1 trial)
raav1.cmv.hufollistatin344 (1 trial)
rasagiline (azilect) (1 trial)
rimabotulinumtoxinB (Myobloc) (2 trials)
sargramostim (leukine) (2 trials)
scaavrh74.tmck.hsgca (1 trial)
tamoxifen (nolvadex) (1 trial)
temozolomide (temodar) (8 trials)
Key: Sarepta Therapeutics (8) Acquired (45)
ethinyl estradiol (Estinyl) (2 trials)
exemestane (aromasin) (1 trial)
fluconazole (diflucan) (2 trials)
flurazepam (dalmane) (1 trial)
incomplete freund's adjuvant (1 trial)
itraconazole (sporanox) (3 trials)
Key: Sarepta Therapeutics (0) Acquired (3)
Cardiovascular Diseases (Phase 2)
Coronary Artery Disease (Phase 2)
Coronary Disease (Phase 2)
Coronary Restenosis (Phase 2)
Encephalitis (Phase 1)
Hemorrhagic Fever, Ebola (Phase 1)
Hemorrhagic Fevers, Viral (Phase 1)
Hepatitis C (Phase 2)
Influenza, Human (Phase 1)
Marburg Virus Disease (Phase 1)
Muscular Dystrophies (Phase 3)
Muscular Dystrophies, Limb-Girdle (Phase 2)
Muscular Dystrophy, Duchenne (Phase 3)
Myocardial Ischemia (Phase 2)
Sarcoglycanopathies (Phase 2)
West Nile Fever (Phase 1)